Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference132 articles.
1. Lung cancer key statistics,2015
2. Primary malignant growths of the lung and bronchi;Adler,1912
3. Comprehensive genomic characterization of squamous cell lung cancers;Nature,2012
4. Comprehensive molecular profiling of lung adenocarcinoma;Nature,2014
5. Clinical implications of genomic discoveries in lung cancer;Swanton;N Engl J Med,2016
Cited by 126 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Challenges in diagnosis and biomarker testing for RET-altered lung and thyroid cancer care: an international mixed-method study;BMC Medical Education;2023-06-05
2. Factors Associated With Receipt of Molecular Testing and its Impact on Time to Initial Systemic Therapy in Metastatic Non-Small Cell Lung Cancer;Clinical Lung Cancer;2023-06
3. Laboratory Practices, Potentiality, and Material Patienthood in Genomic Cancer Medicine;Science, Technology, & Human Values;2023-05-04
4. Targeting diacylglycerol kinase α impairs lung tumorigenesis by inhibiting cyclin D3;Thoracic Cancer;2023-03-25
5. The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care;British Journal of Cancer;2023-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3